CVE-2021-47858: Genexis Platinum-4410
High severity, CVSS 7.2. EPSS: 0.3% chance of exploitation in the next 30 days.
Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged users when they access the security management page.
Affected products
- Genexis Platinum-4410
Published 2026-01-21. Last modified 2026-06-17.